Replacement of in vivo tests for eye iirritation

Linda Birr-Pixton made this Freedom of Information request to Medicines and Healthcare Products Regulatory Agency Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

The request was successful.

Linda Birr-Pixton

Dear Medicines and Healthcare Products Regulatory Agency,
The Department of Health and Social Care, confirmed in response to FOI 1500415 that you are regulatory body responsible for the batch testing of products for eye irritation.
What advice are you, providing the laboratories providing the batch testing of products for eye irritation given that you subscribe to the 3R's and will know that all eye irritation tests have replaced 'in vivo' tests with 'in vitro'.
Please could you direct me to the guidance you are providing on this matter.

Yours faithfully,

Linda Birr-Pixton

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Experience
Centre Team. We will respond to you as soon as possible.

 

Please note that we may not respond if your query:

·         contains offensive language

·         has already been answered in a previous reply to you

·         is illegible

·         is selling or promoting a product

·         is for information only

 

Kind regards

MHRA Customer Experience Centre

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

DISCLAIMER This email and any files transmitted with it are confidential.
If you are not the intended recipient, any reading, printing, storage,
disclosure, copying or any other action taken in respect of this email is
prohibited and may be unlawful. If you are not the intended recipient,
please notify the sender immediately by using the reply function and then
permanently delete what you have received. Incoming and outgoing email
messages are routinely monitored for compliance with the Department of
Health's policy on the use of electronic communications. For more
information on the Department of Health's email policy, click
[1]DHTermsAndConditions

References

Visible links
1. file:///tmp/%20https:/www.gov.uk/help/terms-conditions

PSM, Medicines and Healthcare Products Regulatory Agency

MHRA reference: FOI2024/00082

Dear Linda Birr-Pixton,

Thank you for your information request, which we received on 1 May. We
have understood your request to be for the following information:

The Department of Health and Social Care, confirmed in response to FOI
1500415 that you are regulatory body responsible for the batch testing of
products for eye irritation.
What advice are you, providing the laboratories providing the batch
testing of products for eye irritation given that you subscribe to the
3R's and will know that all eye irritation tests have replaced 'in vivo'
tests with 'in vitro'.
Please could you direct me to the guidance you are providing on this
matter.

If we have misunderstood or misinterpreted your request, please contact us
as soon as possible.

We will deal with your request under the Freedom of Information Act 2000
(FOIA). The statutory time frame for response is 20 working days; this
begins on the first working day after receipt, and we will respond by 31st
May.

If you need to contact us about this request, please quote the reference
number above.

We publish our responses to FOI requests with requester details removed.
You can view these on our website here:

[1]Transparency and freedom of information releases - GOV.UK (www.gov.uk)

Yours sincerely

Safety and Surveillance Group

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000

[2]gov.uk/mhra

[3]Stay connected

For information on how the Agency uses your personal data and your data
protection rights, please see our three centres' Privacy Notices: [4]MHRA,
[5]CPRD and [6]NIBSC.

Appeal rights

If you are dissatisfied with the handling of your request, you have the
right to ask for an internal review. Internal review requests should be
submitted within two months of the date you receive this response and
addressed to: [email address]

If you remain dissatisfied with the outcome of the internal review, you
have the right to apply directly to the Information Commissioner for a
decision. Please bear in mind that the Information Commissioner will not
normally review our handling of a request unless the requester has first
asked us to conduct an internal review.

The Information Commissioner can be contacted through their online webform
at:
[7]https://ico.org.uk/make-a-complaint/foi-...

Or in writing to: Information Commissioner's Office, Wycliffe House, Water
Lane, Wilmslow, Cheshire, SK9 5AF

References

Visible links
1. https://eur01.safelinks.protection.outlo...
2. https://eur01.safelinks.protection.outlo...
3. https://eur01.safelinks.protection.outlo...
4. https://eur01.safelinks.protection.outlo...
5. https://eur01.safelinks.protection.outlo...
6. https://eur01.safelinks.protection.outlo...
7. file:///tmp/http:/about:blank/

[Name removed], Medicines and Healthcare Products Regulatory Agency

1 Attachment

Dear Linda Birr-Pixton,

I am writing in response to your request for information, received 1st
May.

Please find the response to your request attached.

Yours sincerely,

Healthcare, Quality and Access Group

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000

[1]gov.uk/mhra

[2]Stay connected

For information on how the Agency uses your personal data and your data
protection rights, please see our three centres' Privacy Notices: [3]MHRA,
[4]CPRD and [5]NIBSC.

References

Visible links
1. https://eur01.safelinks.protection.outlo...
2. https://eur01.safelinks.protection.outlo...
3. https://eur01.safelinks.protection.outlo...
4. https://eur01.safelinks.protection.outlo...
5. https://eur01.safelinks.protection.outlo...